Armen Mardiros1, Stephen J Forman, Lihua E Budde. 1. aKite Pharma, Inc., Santa Monica bDepartment of Hematology & Hematopoietic Cell Transplantation cDepartment of Cancer Immunotherapeutics dDepartment of Tumor Immunology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this article is to discuss the rationale of targeting CD123 using chimeric antigen receptor (CAR) T cells for the treatment of leukemia. RECENT FINDINGS: CD123 is a leukemia-associated antigen that expresses at high levels in leukemic stem cells and leukemic blasts and low level in normal hematopoietic stem/progenitor cells. Immune-based therapies targeting CD123 are being developed. Preclinical data suggest that CD123 CAR T cells exhibit potent antileukemic activity and various impacts on normal hematopoiesis. SUMMARY: CD123 is an attractive surface target for novel antileukemic therapies. CD123 CAR T-cell-based immunotherapy is a promising treatment for patients with relapsed or refractory acute myeloid leukemia.
PURPOSE OF REVIEW: The purpose of this article is to discuss the rationale of targeting CD123 using chimeric antigen receptor (CAR) T cells for the treatment of leukemia. RECENT FINDINGS:CD123 is a leukemia-associated antigen that expresses at high levels in leukemic stem cells and leukemic blasts and low level in normal hematopoietic stem/progenitor cells. Immune-based therapies targeting CD123 are being developed. Preclinical data suggest that CD123CAR T cells exhibit potent antileukemic activity and various impacts on normal hematopoiesis. SUMMARY:CD123 is an attractive surface target for novel antileukemic therapies. CD123CAR T-cell-based immunotherapy is a promising treatment for patients with relapsed or refractory acute myeloid leukemia.
Authors: Arthur E Frankel; Jung H Woo; Chul Ahn; Naveen Pemmaraju; Bruno C Medeiros; Hetty E Carraway; Olga Frankfurt; Stephen J Forman; Xuezhong A Yang; Marina Konopleva; Francine Garnache-Ottou; Fanny Angelot-Delettre; Christopher Brooks; Michael Szarek; Eric Rowinsky Journal: Blood Date: 2014-05-23 Impact factor: 22.113
Authors: Shannon L Maude; Noelle Frey; Pamela A Shaw; Richard Aplenc; David M Barrett; Nancy J Bunin; Anne Chew; Vanessa E Gonzalez; Zhaohui Zheng; Simon F Lacey; Yolanda D Mahnke; Jan J Melenhorst; Susan R Rheingold; Angela Shen; David T Teachey; Bruce L Levine; Carl H June; David L Porter; Stephan A Grupp Journal: N Engl J Med Date: 2014-10-16 Impact factor: 91.245
Authors: Xiuli Wang; Wen-Chung Chang; ChingLam W Wong; David Colcher; Mark Sherman; Julie R Ostberg; Stephen J Forman; Stanley R Riddell; Michael C Jensen Journal: Blood Date: 2011-06-07 Impact factor: 22.113
Authors: Marco L Davila; Isabelle Riviere; Xiuyan Wang; Shirley Bartido; Jae Park; Kevin Curran; Stephen S Chung; Jolanta Stefanski; Oriana Borquez-Ojeda; Malgorzata Olszewska; Jinrong Qu; Teresa Wasielewska; Qing He; Mitsu Fink; Himaly Shinglot; Maher Youssif; Mark Satter; Yongzeng Wang; James Hosey; Hilda Quintanilla; Elizabeth Halton; Yvette Bernal; Diana C G Bouhassira; Maria E Arcila; Mithat Gonen; Gail J Roboz; Peter Maslak; Dan Douer; Mark G Frattini; Sergio Giralt; Michel Sadelain; Renier Brentjens Journal: Sci Transl Med Date: 2014-02-19 Impact factor: 17.956
Authors: Eva Nievergall; Hayley S Ramshaw; Agnes S M Yong; Mark Biondo; Samantha J Busfield; Gino Vairo; Angel F Lopez; Timothy P Hughes; Deborah L White; Devendra K Hiwase Journal: Blood Date: 2013-12-20 Impact factor: 22.113
Authors: Simon Z He; Samantha Busfield; David S Ritchie; Mark S Hertzberg; Simon Durrant; Ian D Lewis; Paula Marlton; Andrew J McLachlan; Ian Kerridge; Kenneth F Bradstock; Glen Kennedy; Andrew W Boyd; Trina M Yeadon; Angel F Lopez; Hayley S Ramshaw; Harry Iland; Simone Bamford; Megan Barnden; Mark DeWitte; Russell Basser; Andrew W Roberts Journal: Leuk Lymphoma Date: 2014-11-20
Authors: David A Sallman; Jason Brayer; Elizabeth M Sagatys; Caroline Lonez; Eytan Breman; Sophie Agaugué; Bikash Verma; David E Gilham; Frédéric F Lehmann; Marco L Davila Journal: Haematologica Date: 2018-04-27 Impact factor: 9.941
Authors: Dyantha I van der Lee; Rogier M Reijmers; Maria W Honders; Renate S Hagedoorn; Rob Cm de Jong; Michel Gd Kester; Dirk M van der Steen; Arnoud H de Ru; Christiaan Kweekel; Helena M Bijen; Inge Jedema; Hendrik Veelken; Peter A van Veelen; Mirjam Hm Heemskerk; J H Frederik Falkenburg; Marieke Griffioen Journal: J Clin Invest Date: 2019-01-14 Impact factor: 14.808
Authors: Haruko Tashiro; Tim Sauer; Thomas Shum; Kathan Parikh; Maksim Mamonkin; Bilal Omer; Rayne H Rouce; Premal Lulla; Cliona M Rooney; Stephen Gottschalk; Malcolm K Brenner Journal: Mol Ther Date: 2017-07-01 Impact factor: 11.454